Ivax Diagnostics, Inc. (IVD) Reports Breakeven Q1

Ivax Diagnostics, Inc. (NYSE: IVD) reported Q1 EPS of $0.00, versus ($0.04) reported last year. Revenue for the quarter came in at $4.27 million, versus $4.13 million reported last year.

For earnings history and earnings-related data on Ivax Diagnostics, Inc. (IVD) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• DeFi Technologies Inc. (DEFT) Reports Q2 Loss of $0.04
• Stardust Power (SDST) Tops Q2 EPS by 1c